The Nuclear Pore Complex and mRNA Export in Cancer

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Messenger RNA (mRNA) export from the nucleus to the cytoplasm is a critical regulatory step in gene expression.
• This process occurs via the nuclear pore complex (NPC) and is influenced by cellular stimuli and stress.
• Specific mRNA export pathways, distinct from bulk export, are mediated by NPC components and co-factors.

Purpose of the Study:

• To describe the fundamental mechanisms of mRNA export, focusing on the export machinery and nuclear pore complex (NPC) components.
• To explore the role of aberrant RNA export in human cancers.
• To discuss therapeutic strategies targeting RNA export pathways in cancer treatment.

Main Methods:

• Review and description of established molecular mechanisms governing mRNA transport through the NPC.
• Analysis of literature linking NPC components and RNA export machinery to cancer pathogenesis.
• Discussion of current and potential therapeutic interventions targeting RNA export.

Main Results:

• Aberrant mRNA export is observed in human cancers, with cargo RNAs encoding proteins involved in malignancy.
• NPC components and RNA export machinery are frequently dysregulated, mutated, or affected by chromosomal translocations in cancer.
• Specific RNA export pathways offer a molecular basis for selective RNA transport independent of bulk export.

Conclusions:

• RNA export is a critical cellular process that, when dysregulated, contributes significantly to cancer development.
• The molecular machinery and NPC components involved in RNA export are implicated in various cancers.
• Targeting RNA export pathways represents a promising therapeutic strategy for cancer, alongside targeting transcription and translation.